The rise in pancreatic cancer diagnoses can be attributed to detection of smaller, early-stage endocrine cancer, and not an increase in pancreatic adenocarcinoma, according to a study published Nov.
The rising incidence of pancreatic cancer among young Americans may largely reflect previously undetected cases not a true rise in occurrence, experts say.